Although CD30 is consistently implicated in lymphocyte malignancies, its precise functional mechanisms in the context of MD remain incompletely understood, warranting further exploration of the molecular pathways underlying its regulation. This evidence concerns the gene TNFRSF8 and Menkes disease.